Comp34 displays potent preclinical antitumor efficacy in triple-negative breast cancer via inhibition of NUDT3-AS4, a novel oncogenic long noncoding RNA.

Hao Q, Wang P, Dutta P, Chung S, Li Q, Wang K, Li J, Cao W, Deng W, Geng Q, Schrode K, Shaheen M, Wu K, Zhu D, Chen QH, Chen G, Elshimali Y, Vadgama J, Wu Y
Cell Death Dis. 2020 Dec 11;11(12):1052. doi: 10.1038/s41419-020-03235-w. PubMed Article

Plasmids from Article

No plasmids are currently publicly available from Addgene for this article.